Active trachoma · people (any age) with active trachoma
1 finding from 1 review
Ocular chlamydia trachomatis infection · people (any age) with active trachoma
1 finding from 1 review
Antibiotic resistance · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
Antibiotics for trachoma 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Adverse effects · people (any age) with active trachoma
1 finding from 1 review
Active trachoma · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
Antibiotics for trachoma 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Vaginal delivery not achieved within 24 hours · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine hyperstimulation with fetal heart rate changes · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious neonatal morbidity or perinatal death · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious maternal morbidity or death · pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant global assessment VAS Visual analogue scale (VAS) (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Pain VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Nodules score Nodule count · participants with hidradenitis suppurativa
1 finding from 1 review
Abscesses score Abscess count · participants with hidradenitis suppurativa
1 finding from 1 review
Physician global assessment VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa
1 finding from 1 review
Number of responders ‐ disease activity not stated (12 weeks) · IBD patients
Oral ferric maltol showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV ferric carboxymaltose (low certainty).
1 finding from 1 review
Serious adverse events (12 weeks) · IBD patients
It is very uncertain whether oral ferric maltol changes serious adverse events (12 weeks) compared with IV ferric carboxymaltose (very low certainty).
1 finding from 1 review
Change in disability score · ambulatory adults with SMA type III
1 finding from 1 review
no estimate extracted
31 participants
Low
Muscle strength · ambulatory adults with SMA type III
1 finding from 1 review
no estimate extracted
30 participants
Low
Acquiring the ability to stand or walk · ambulatory adults with SMA type III
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found